Analogue Z
ID: ALA1159506
PubChem CID: 44272918
Max Phase: Preclinical
Molecular Formula: C23H45N5O14
Molecular Weight: 615.63
Molecule Type: Small molecule
Associated Items:
This compound is not in our inventory system
ID: ALA1159506
PubChem CID: 44272918
Max Phase: Preclinical
Molecular Formula: C23H45N5O14
Molecular Weight: 615.63
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCC1OC(OC2C(N)CC(N)C(O)C2OC2OC(CO)C(OC3OC(CN)C(O)C(O)C3O)C2O)C(N)C(O)C1O
Standard InChI: InChI=1S/C23H45N5O14/c24-2-7-12(31)14(33)10(28)21(37-7)40-18-6(27)1-5(26)11(30)20(18)42-23-17(36)19(9(4-29)39-23)41-22-16(35)15(34)13(32)8(3-25)38-22/h5-23,29-36H,1-4,24-28H2
Standard InChI Key: HTGNYGXWPSCVJB-UHFFFAOYSA-N
Molfile:
RDKit 2D 42 45 0 0 0 0 0 0 0 0999 V2000 6.6042 -3.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4917 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0292 -4.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4792 -4.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8542 -1.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4917 -5.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0292 -2.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.6667 -5.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5917 -3.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0167 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8667 -4.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9417 -2.9875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.0792 -4.1167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.0417 -0.7500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7042 -4.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.9792 -5.9417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.4917 -2.2625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7.5417 -2.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1167 -3.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4917 -1.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1292 -4.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5417 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1292 -1.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.2667 -3.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7542 -2.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6542 -2.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7167 -2.1667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.9792 -2.8000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.1417 -0.0792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.1792 -4.9167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.7042 -5.9042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1792 -3.0250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.8667 -5.1042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.3792 -1.8792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.6917 -1.8542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 7.5542 -3.4292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7542 -1.2167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.5417 -4.0917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.7792 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0125 -5.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1292 -4.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6167 -3.7750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 17 1 0 3 12 1 0 4 16 1 0 5 2 1 0 6 8 1 0 7 1 1 0 8 3 1 0 9 4 1 0 10 5 1 0 11 9 1 0 12 1 1 0 13 3 1 0 14 2 1 0 15 4 1 0 16 6 1 0 17 7 1 0 18 1 1 0 19 22 1 0 20 23 1 0 21 13 1 0 22 15 1 0 23 14 1 0 24 18 1 0 25 7 1 0 26 24 1 0 27 5 1 0 28 24 1 0 29 39 1 0 30 40 1 0 31 8 1 0 32 9 1 0 33 11 1 0 34 10 1 0 35 25 1 0 36 18 1 0 37 20 1 0 38 19 1 0 39 23 1 0 40 22 1 0 41 21 1 0 42 41 1 0 26 25 1 0 21 6 1 0 20 10 1 0 11 19 1 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 615.63 | Molecular Weight (Monoisotopic): 615.2963 | AlogP: -8.86 | #Rotatable Bonds: 9 |
Polar Surface Area: 347.32 | Molecular Species: BASE | HBA: 19 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 18 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.92 | CX Basic pKa: 9.59 | CX LogP: -8.31 | CX LogD: -14.56 |
Aromatic Rings: ┄ | Heavy Atoms: 42 | QED Weighted: 0.11 | Np Likeness Score: 1.25 |
1. Cashman DJ, Rife JP, Kellogg GE.. (2001) Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues., 11 (2): [PMID:11206440] [10.1016/s0960-894x(00)00615-6] |
Source(1):